| therapeutics | target | indications | discovery | non-clinical | clinical |
|---|---|---|---|---|---|
| Small molecules | CR-E1 | Autoimmune disease* | on | on | |
| B-cell lymphoma | on | ||||
| Gene therapy | CR-P1 | NASH | on | on | |
| HCC | on | ||||
| Therapeutic proteins | CR-T1~T4 | Autoimmune disease* | on | on | |
| CR-T5~T8 | NASH | on |
* Our autoimmune disease treatment candidates are being developed as indications for psoriasis, psoriatic arthritis, rheumatoid arthritis and/or inflammatory bowel disease. Indications will be extended to ankylosing spondylitis and graft-versus-host disease on medical and experimental basis.